08/11/2025 7:43 AM | BioNTech (Filer)
| Form F-4 Registration statement for securities of certain foreign private issuers issued in certain business combination transactions | |
08/11/2025 5:37 AM | BioNTech (Filed by) CureVac N.V. (Subject)
| Form 425 | |
08/11/2025 5:24 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/04/2025 6:57 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/04/2025 7:01 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/25/2025 7:53 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/17/2025 7:32 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2025 3:40 PM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2025 3:47 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144/A | |
06/04/2025 7:31 AM | BioNTech (Subject) Jeggle Helmut Wolfgang (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/02/2025 6:20 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for BNTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BioNTech and its competitors with MarketBeat's FREE daily newsletter.
|
05/28/2025 8:00 AM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2025 7:58 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2025 5:14 PM | BioNTech (Subject) Medine GmbH (Filed by)
| Form SCHEDULE 13G/A | |
05/07/2025 6:30 AM | BioNTech (Subject) Jeggle Helmut Wolfgang (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/05/2025 6:33 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/05/2025 5:53 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/05/2025 5:33 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2025 6:54 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/10/2025 5:57 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/10/2025 6:00 AM | BioNTech (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
02/27/2025 6:57 AM | BioNTech (Subject) Richardson Ryan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2025 6:53 AM | BioNTech (Subject) Medine GmbH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2025 6:50 AM | BioNTech (Subject) Poetting Sierk (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025 6:02 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/14/2025 5:58 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2024 6:25 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2024 6:21 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/13/2024 4:56 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024 4:25 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/09/2024 5:35 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024 4:57 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024 4:50 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024 5:37 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024 4:06 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024 6:38 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2024 5:49 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024 5:53 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024 5:57 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/18/2024 8:04 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/16/2024 4:03 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
My shocking meeting in Washington, D.C. (Ad) After a shocking discovery in D.C., Jeff Brown is revealing:
President Trump’s “Project MAFA”
Get a look inside Trump’s genius master plan to create a “new” gold standard, smash the U.S. debt, and kick off a Golden Century. You can watch it right here. |
10/15/2024 7:41 AM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2024 3:15 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2024 3:13 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024 3:24 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/04/2024 3:17 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024 4:14 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024 5:18 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/01/2024 7:12 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024 3:52 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024 4:12 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/25/2024 6:14 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024 8:17 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024 6:28 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 4:35 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024 7:53 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/22/2024 3:31 PM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/19/2024 7:34 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/16/2024 5:56 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |